PROFUSA Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

-36m

L+288.11%

CFO

-16m

L+686.45%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Key people

Bill Mcmillan

Co-Founder, Chief Scientific Officer, Head of Research · since 2022

Kerstin Rebrin

Vice President of Medical Affairs and Clinical Development

Phil Constantinou

Head of Software and Data Science

Sean Givens

Head - Government Business

Ben Hwang

Chairman of the Board, Chief Executive Officer

URL

https://profusa.com/

IPO date

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title in thousands, except ratios and share amounts	FY	FY	FY	FY	FY
Title in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT